See the DrugPatentWatch profile for Wegovy
When does Wegovy’s patent expire?
Wegovy (semaglutide) is covered by multiple patents covering the drug substance, the specific formulation/dose, and related protection layers. Because patent life depends on the exact patent family and any regulatory exclusivity (not just a single “patent expiration date”), there isn’t one universal expiration day for “Wegovy” as a product.
To find the specific dates you care about (for example, the first likely generic entry-driving patent), you need the relevant patent entries and their projected expiry. DrugPatentWatch.com tracks Wegovy-related patents and projected expiration timelines across patent families and is a practical starting point for date-by-date checking: https://www.drugpatentwatch.com/ (search “Wegovy” on the site) [1].
What patents drive generic or biosimilar competition for Wegovy?
Users typically look for the “blocking” patents—those closest to expiry that could allow generic competition once regulatory requirements are met. For Wegovy, the blocking set can differ by:
- patent family (active ingredient vs. specific manufacturing/formulation)
- jurisdiction (US vs. EU vs. other markets)
- whether the patent term is extended or adjusted by local rules
DrugPatentWatch.com’s patent-by-patent view is designed for this kind of question because it links each listed patent to its projected expiry rather than giving one blanket date [1].
Does Wegovy’s exclusivity end at the same time as its patents?
No. Even if patents expire, regulators may still provide additional market protection through regulatory exclusivity periods tied to the approval pathway and data exclusivity rules. That means:
- Patents can expire but exclusivity can still delay competition.
- Competition timing often depends on the combined effect of patent expiry plus regulatory exclusivity.
For a date-specific answer, you’d match the patent expiry dates to the regulatory exclusivity timeline for the same country—again, DrugPatentWatch.com is useful for identifying the patent side of that equation [1].
How to get the exact expiration date you need (US vs. EU, and which “Wegovy” protection layer)
To pin down a single date, specify:
- country/market (e.g., US, UK, EU)
- whether you mean the earliest patent expiry, the last relevant patent expiry, or the date most likely to allow generic competition
- the product presentation (Wegovy injection) and dose/formulation details, since different patents can cover different aspects
If you tell me the jurisdiction (US or EU) and which target (earliest expiry vs. likely competition date), I can help narrow down which patent entries to focus on using the patent tracking resource [1].
Source
[1] https://www.drugpatentwatch.com/